AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27866182
Drug: Homeopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic treatment (9 drugs including Pulsatilla nigricans, Sepia succus, Lycopodium clavatum, sulphur, Lachesis trigonocephalus, Nux vomica, Calcarea carbonica, phosphorus, Conium maculatum) administered as 6 drops orally 2 times per day for 4 consecutive days each week, with a 3-day interval between doses.
Trial: 1444292
Drug: Cefotaxime, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime, 2 g intravenously at 6‐h intervals during surgery and then at 8‐h intervals thereafter for 48 h
Trial: 1444292
Drug: Ampicillin, 2
RxNorm normalized name: Ampicillin, 250 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin, 2 g intravenously at the same dose and schedule as cefotaxime
Trial: 1444292
Drug: Systemic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antibiotics plus a 3‐week regimen of oral nonabsorbable antibiotics (gentamicin, polymyxin E, and nystatin)
Trial: 8403669
Drug: Systemic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antibiotics alone
Trial: 18708988
Drug: Intraarticular lumbar
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraarticular lumbar facet joint injections with lidocaine and triamcinolone
Trial: 12209099
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg/d for 6 weeks
Trial: 1763561
Drug: Misoprostol (MS)
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol (MS) therapy
Trial: 6433840
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose urokinase (UKl)
Trial: 6433840
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose urokinase (UKh)
Trial: 29630134
Drug: Voriconazole sequential
RxNorm normalized name: Voriconazole
DrugBank: Voriconazole (DB00582)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Voriconazole sequential therapy
Trial: 27292585
Drug: Testosterone therapy
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone therapy every 2 weeks for 15 weeks
Trial: 27292585
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment every 2 weeks for 15 weeks
Trial: 12891248
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg/day)
Trial: 2004805
Drug: Diltiazem (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (90 mg/day)
Trial: 24256699
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fluvastatin (40 mg/day) and diltiazem (90 mg/day)
Trial: 22479786
Drug: Water-only preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water-only preparation
Trial: 15574070
Drug: KLIP program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KLIP program (knee ligament injury prevention program), low-intensity plyometric exercises, 9 weeks duration, twice a week
Trial: 1489073
Drug: Magnesium aspartate
RxNorm normalized name: Magnesium aspartate
DrugBank: Magnesium aspartate hydrochloride (DB16619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium aspartate infusion (0.8 mEq/kg per h for 15 min, then reduced to 0.2 mEq/kg per h until aortic cannulation)
Trial: 17694684
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no magnesium infusion)
Trial: 1489073
Drug: Magnesium aspartate
RxNorm normalized name: Magnesium aspartate
DrugBank: Magnesium aspartate hydrochloride (DB16619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium aspartate infusion
Trial: 28659614
Drug: Transcranial static
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial static magnetic field stimulation (tSMS) ON medication.
Trial: 21385988
Drug: Rolapitant 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolapitant 20 mg
Trial: 21385988
Drug: Rolapitant 70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolapitant 70 mg
Trial: 9014006
Drug: Inactivated combined
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated combined vaccine (ICV) against Q fever
Trial: 1547611
Drug: Bi-annual topical
RxNorm normalized name: annual bluegrass pollen extract
DrugBank: Poa annua pollen (DB10353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bi-annual topical APF gel applications
Trial: 2860494
Drug: Tri-potassium di-citrato
RxNorm normalized name: di-isopropylammonium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tri-potassium di-citrato bismuthate (TDB) tablet four times a day
Trial: 28801122
Drug: Serum deoxycholic
RxNorm normalized name: deoxycholate
DrugBank: Deoxycholic acid (DB03619)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Serum deoxycholic acid concentration > 58ng/mL
Trial: 3302916
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment (48 to 56 hours)
Trial: 3302916
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (aspirin or acetaminophen)
Trial: 22042749
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate nasal spray 400 µg twice daily
Trial: 17569711
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.60 mg/kg of body weight
Trial: 10567626
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (100 mg)
Trial: 8918323
Drug: 200 IU/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 IU/kg once-daily dalteparin (group 1)
Trial: 6749604
Drug: Branched-chain amino
RxNorm normalized name: Branched-chain amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Branched-chain amino acids (30 g) for longer periods (5 to 22 weeks)
Trial: 26257021
Drug: Double-dose (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose (40 μg) recombinant hepatitis B vaccine at weeks 0, 4, and 24
Trial: 26257021
Drug: Standard-dose (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (20 μg) recombinant hepatitis B vaccine at weeks 0, 4, and 24
Trial: 26257021
Drug: Double-dose (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose (40 μg) group
Trial: 26257021
Drug: Standard-dose (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose (20 μg) group
Trial: 24979519
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine A (CsA) 0.05% eyedrops
Trial: 19397693
Drug: Fluvastatin/fenofibrate (80/200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin/fenofibrate (80/200 mg)
Trial: 19397693
Drug: Simvastatin/ezetimibe (20/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin/ezetimibe (20/10 mg)
Trial: 2993687
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (5 g)
Trial: 2451578
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml dextran 70 in saline solution
Trial: 2451578
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml saline solution (control)
Trial: 28898104
Drug: Ultrasound-guided barbotage
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided barbotage combined with a subacromial corticosteroid injection (SAIC)
Trial: 21428979
Drug: Calcipotriol cream
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriol cream applied twice daily for 7 days before photoprovocation testing
Trial: 21428979
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream applied twice daily for 7 days before photoprovocation testing
Trial: 9292632
Drug: Alprazolam (0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (0.75 mg) administered on days 2 and 11
Trial: 8385974
Drug: 0.01 mg
RxNorm normalized name: urea 0.01 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg kg‐1 intravenously (i.v.)
Trial: 8385974
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg kg‐1 intravenously (i.v.)
Trial: 8385974
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg kg‐1 orally (p.o.)
Trial: 8385974
Drug: 0.03 mg
RxNorm normalized name: biotin 0.03 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.03 mg kg‐1 intravenously (i.v.)
Trial: 8385974
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg kg‐1 intravenously (i.v.)
Trial: 8385974
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg kg‐1 orally (p.o.) and 0.3 mg kg‐1 orally (p.o.)
Trial: 3348613
Drug: Intravenous dosing
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dosing
Trial: 3519094
Drug: Controlled-release formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release formulation of ketoprofen
Trial: 3519094
Drug: Standard formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard formulation of ketoprofen
Trial: 30635020
Drug: Sildenafil 25
RxNorm normalized name: sildenafil 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 25 mg orally three times a day
Trial: 29554173
Drug: Vaginal 10-μg
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal 10-μg estradiol tablet (daily for 2 weeks, then twice weekly) plus placebo gel (3 times a week)
Trial: 25605283
Drug: Clofazimine (Cfz)
RxNorm normalized name: Clofazimine
DrugBank: Clofazimine (DB00845)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clofazimine (Cfz) therapy group (n = 53)
Trial: 23046862
Drug: Phaseolus vulgaris
RxNorm normalized name: PHASEOLUS VULGARIS WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phaseolus vulgaris extract (PVE) 100 mg
Trial: 16983393
Drug: Dutasteride (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride (0.5 mg daily for 2 years)
Trial: 12826249
Drug: Concurrent paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Concurrent paclitaxel with external beam radiotherapy
Trial: 12826249
Drug: Concurrent paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Concurrent paclitaxel and gemcitabine with RT followed by R115777
Trial: 9355184
Drug: Argon green
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon green laser treatment applied directly to the soft drusen in the temporal macula (Group 2)
Trial: 9355184
Drug: Argon green
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon green laser treatment applied directly to the soft drusen in the temporal macula (Group 1)
Trial: 3016111
Drug: Intranasal recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal recombinant interferon (rIFN; 2 X 10(6) IU/day)
Trial: 30129268
Drug: Single-tufted toothbrush
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-tufted toothbrush and conventional toothbrush combination (Group 3)
Trial: 28028253
Drug: Intraperitoneal chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chemotherapy regimen of S‐1 combined with weekly intravenous and IP paclitaxel (PTX) administration, with a recommended dose of IP PTX being 20 mg/m2.
Trial: 28028253
Drug: Intraperitoneal chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chemotherapy regimen of S‐1 combined with weekly intravenous and IP paclitaxel (PTX) administration for P1 gastric cancer.
Trial: 28028253
Drug: Intraperitoneal chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal chemotherapy (IP chemotherapy)
Trial: 28028253
Drug: Intraperitoneal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal administration of docetaxel
Trial: 18087204
Drug: Maintenance antidepressant
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance antidepressant (AD) medication
Trial: 18087204
Drug: Intermittent use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent use of antidepressants
Trial: 1751434
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg mifepristone orally 36 h before operation
Trial: 1751434
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg gemeprost vaginal pessary 3‐4 h preoperatively
Trial: 25027701
Drug: Placebo (identical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (identical oral placebo)
Trial: 23128033
Drug: Er:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er:YAG laser treatment at 5.1 J/cm² (L(1))
Trial: 23128033
Drug: Er:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er:YAG laser treatment at 2.0 J/cm² (L(2))
Trial: 11769363
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (hospital ward treatment)
Trial: 12086760
Drug: Acarbose 100
RxNorm normalized name: acarbose 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 100 mg three times daily
Trial: 7555508
Drug: Acarbose 200
RxNorm normalized name: Acarbose
DrugBank: Acarbose (DB00284)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acarbose 200 mg three times daily
Trial: 7555508
Drug: Acarbose 300
RxNorm normalized name: Acarbose
DrugBank: Acarbose (DB00284)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acarbose 300 mg three times daily
Trial: 7555508
Drug: Acarbose (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (all doses)
Trial: 446319
Drug: Cimetidine 1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1.6 g/d
Trial: 28241356
Drug: Placebo gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gel for 1 year
Trial: 24281841
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein (38 g protein)
Trial: 20231228
Drug: Fentanyl (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (2 microg/kg) and succinylcholine (2 mg/kg)
Trial: 17664059
Drug: Infant formula
RxNorm normalized name: Infant formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infant formula with 0.6 g/100 mL of galacto-oligosaccharides (GOS) and long-chain fructo-oligosaccharides (lcFOS) in a ratio of 9/1
Trial: 12475852
Drug: Diuretics and
RxNorm normalized name: Low-ceiling diuretics and potassium-sparing agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics and colloids
Trial: 31812702
Drug: Astodrimer 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astodrimer 1% Gel
Trial: 31812702
Drug: Placebo Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo Gel
Trial: 27156803
Drug: Medical needling
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical needling combined with non-cultured autologous skin cell suspension (NCASCS)
Trial: 22956551
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oral prednisolone daily for 4 weeks
Trial: 16211697
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (CE) and medroxyprogesterone acetate (MPA) at a dose of 0.3/1.5 mg daily for 24 weeks
Trial: 11846190
Drug: Meloxicam 7.5
RxNorm normalized name: meloxicam 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 7.5 mg
Trial: 10325662
Drug: Meloxicam 22.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 22.5 mg
Trial: 19380329
Drug: Diclofenac 150
RxNorm normalized name: diclofenac sodium 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 150 mg
Trial: 6679229
Drug: Oral drug
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral drug therapy
Trial: 1760998
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (6 g daily for four weeks)
Trial: 31593070
Drug: Conventional Oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Oxygen Therapy (COT)
Trial: 30089430
Drug: 10,000 therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10,000 therapeutic units (TU) of Dermatophagoides pteronyssinus allergoid preparation
Trial: 30089430
Drug: 18,000 therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18,000 therapeutic units (TU) of Dermatophagoides pteronyssinus allergoid preparation
Trial: 24663007
Drug: Herbst appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Herbst appliance therapy
Trial: 22324448
Drug: Synbiotic formulation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic formulation containing Lactobacillus paracasei B21060, arabinogalactan and xilooligosaccharides
Trial: 17608790
Drug: AGT-6 genotype
RxNorm normalized name: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
DrugBank: Streptococcus pneumoniae type 8 capsular polysaccharide antigen (DB10326)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGT-6 genotype 'G/G' in men
Trial: 17608790
Drug: AGT-6 genotype
RxNorm normalized name: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
DrugBank: Streptococcus pneumoniae type 8 capsular polysaccharide antigen (DB10326)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGT-6 genotype 'G/G' in women
Trial: 2644753
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural analgesia (TEA) with bupivacaine 50 mg via an epidural catheter, maintained by continuous infusion for 24 hours postoperatively.
Trial: 186225
Drug: Renal arterial
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renal arterial infusion of orthophosphate (Pi) in dogs
Trial: 16562706
Drug: Daily health
RxNorm normalized name: Walgreens One Daily Healthy Weight Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily health education at DOTS centres
Trial: 9013264
Drug: Dobutamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine infusion (3 micrograms/kg/min)
Trial: 3877283
Drug: 0.05 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 ml/kg Althesin
Trial: 11719310
Drug: Nocturnal oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nocturnal oxygen therapy (NOT)
Trial: 30407969
Drug: Auditory stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auditory stimulation by a male nurse, recorded on MP3, administered twice a day for 10 days, repeated 3 to 4 times.
Trial: 27391818
Drug: Structured multi‐component
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured multi‐component intervention (algorithm‐driven intervention using fixed‐dose combination antihypertensive treatment, subsidized FDC antihypertensive medication, motivational conversation, telephone follow‐ups)
Trial: 12523588
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg b.i.d
Trial: 1672578
Drug: vecuronium 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vecuronium 0.4 mg/kg
Trial: 1672578
Drug: succinylcholine 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: succinylcholine 2.0 mg/kg
Trial: 2905566
Drug: vecuronium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vecuronium 0.1 mg/kg
Trial: 1672578
Drug: vecuronium 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vecuronium 0.2 mg/kg
Trial: 28337838
Drug: mavoglurant 50
RxNorm normalized name: Mavoglurant
DrugBank: Mavoglurant (DB13004)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mavoglurant 50 mg
Trial: 21360203
Drug: Combined HI-RT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined HI-RT and low-intensity blood flow restriction training (CB-RT, twice-weekly LI-BFR and once-weekly HI-RT)
Trial: 19726310
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with laparoscopy, endoscopic and digital subtraction angiography in addition to conventional treatment (group B)